Effect of iodine supplement on iodine status and 5′-deiodinase activity in the brain of neonatal rats with iodine deficiency

Biological Trace Element Research

Volumn 114, Issue 1-3, 2006, Pages 207-215

  Liu, Nianqing ^a   Zuo, Aijun ^b   Liang, Dongchun ^b   Zhang, Zhiyong ^a   Guo, Gang ^b   Chai, Zhifang ^a  

^a INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^b Tianjin Institute of Endocrinology   (China)

Author keywords

5 deiodinase; Iodine deficiency; Iodine excess; Iodine level in thyroid; Thyroid hormones

Indexed keywords

3,3',5' TRIIODOTHYRONINE; IODINE; LIOTHYRONINE; POTASSIUM IODATE; THYROXINE; THYROXINE 5 DEIODINASE; THYROXINE DEIODINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GOITER; IODINE DEFICIENCY; LIOTHYRONINE METABOLISM; MALE; NEUTRON ACTIVATION ANALYSIS; NEWBORN; NONHUMAN; RAT; SUPPLEMENTATION; THYROID HORMONE BLOOD LEVEL; THYROXINE METABOLISM;

RATTUS; RATTUS NORVEGICUS;

EID: 33846244689     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:114:1:207     Document Type: Article

References (24)

1. J. S. Chen and H. Y. Wu, Fortification of salt with iodine, International Life Sciences Institute Regional Conference on Food Fortification: Science, Technology, and Policy, Food Nutr. Bull. 19(2) (1998).
2. M. Hufner, Thyroid hormones in the treatment of iodine deficiency goiter. Superfluous like goiter? MMW Fortschr. Med. 144(9), 26-29 (2002).
3. F. Delange, Neonatal hypothyroidism: recent developments, Baillieres Clin. Endocrinol. Metab 2(3), 637-652 (1988).
4. N. Koibuchi and W. W. Chin, Thyroid hormone action and brain development, Trends Endocrinol. Metab. 11(4), 123-128 (2000).
5. F. Delange, H. Burgi, Z. P. Chen, et al., World status of monitoring iodine deficiency disorders control programs, Thyroid 12(10), 915-924 (2002).
6. F. Delange, B. de Benoist, and D. Alnwick, Risks of iodien-induced hyperthyroidism after correction of I deficiency by iodized salt, Thyroid 9(6), 545-556 (1999).
7. J. R. Arthur and G. Beckett, Thyroid function, Br. Med. Bull. 55(3), 658-668 (1999).
8. X. L. Hou, K. Wang, and Z. F. Chai, Epithermal neutron activation analytical and its application in the miniature neutron source reactor, J Radioanal. Nucl. Chem. 210(1), 137-148 (1996).
9. Committee on Standards for Nutritional Studies. Report of the American Institute of Nutrition Ad hoc Committee on Standards for Nutritional Studies, J. Nutr. 107, 1340-1348 (1977).
10. I. J. Chopra, A study of extrathyroidal conversion of thyroxine (T4) to 3,3′,5′-triiodothyronine (T3) in vitro, Endocrinology 101, 453-463 (1977).
11. R. R. Cavalieri, L. A. Gavin, F. Bui, et al., Conversion of thyroxine to 3,3′,5′-triiodothyronine (reverse-T3) by a soluble enzyme system of rat liver, Biochem. Biophys. Res. Commun. 79(3), 897-902 (1977).
12. E. A. Jannini, E. Carosa, F. M. Graziano, et al., Iodine deficiency diseases and pregnancy Minerva, Endocrinology 19(3), 149-154 (1994).
13. N. Q. Liu, Q. Xu, X. L. Hou, et al., Correlation analyses between trace elements and thyroid hormone of cretinism Rats, Brain Res. Bull. 55(2), 309-312 (2001).
14. A. J. Zuo, X. Q. Zhao, D. C. Liang, et al., Influence of iodine supplement on thyroid hormone receptor in brain of I deficiency rats, Chin. J. Endocrinol. 23(3), 198-200 (2004).
15. G. F. Ana, J. E. Maria, R. Estrella, et al., Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems, J. Neurosci. 19(9), 3430-3439 (1999).
16. M. J. Berry, L. Banu, and P. R. Larsen, Type I iodothyronine deiodinase is a selenocysteine. containing enzyme, Nature 349, 438-440 (1991).
17. D. Salvatore, T. Bartha, J. W. Harney, et al., Molecular biological and biochemical characterization of the human type 2 selenodeiodinase, Edocrinology 137(7), 3308-3315 (1996).
18. M. Ramauge, S. Pallud, A. Esfandiari, et al., Evidence that type III iodothyronine deiodinase in rat astrocyte is a selenoprotein, Endocrinology 137(7), 3021-3025 (1996).
19. K. B. Markou, P. Paraskevopoulou, K. S. Karaiskos, et al., Hyperthyrotropinemia during iodide administration in normal children and in children born with neonatal transient hypothyroidism, J. Clin. Endocrinol. Metab. 88(2), 617-621 (2003).
20. F. Delange, The role of I in brain development, Proceed. Nutr. Soc. 59, 75-79 (2000).
21. A. W. Kung, T. T. Lao, M. T. Chau, et al., Goitrogenesis during pregnancy and neonatal hypothyroxinaemia in a borderline I sufficient area, Clin. Endocrinol. (Oxf.) 53(6), 725-731 (2000).
22. F. Calaciura, G. Mendorla, M. Distefano, et al., Childhood IQ measurements in infants with transient neonatal hypothyroidism, Clin. Endocrinol. (Oxf.) 43(4), 473-477 (1995).
23. Van Vliet, G. Neonatal hypothyroidism: treatment and outcome, Thyroid 9, 79-84 (1999).
24. I. B. Pedersen, N. Knudsen, T. Jørgensen, et al., Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in I intake: a prospective comparative register-based population survey, J. Clin. Endocrinol. Metab. 87(10), 4462-4469 (2002).